211 related articles for article (PubMed ID: 34176457)
1. The Therapeutic Potential of Targeting the Angiotensin Pathway as a Novel Therapeutic Approach to Ameliorating Post-surgical Adhesions.
Khalili-Tanha G; Khalili-Tanha N; Nazari SE; Chaeichi-Tehrani N; Khazaei M; Aliakbarian M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(3):180-186. PubMed ID: 34176457
[TBL] [Abstract][Full Text] [Related]
2. Local renin-angiotensin system molecular mechanisms in intrauterine adhesions formation following gynecological operations, new strategy for novel treatment.
Shabanian S; Khazaie M; Ferns GA; Arjmand MH
J Obstet Gynaecol; 2022 Aug; 42(6):1613-1618. PubMed ID: 35260037
[TBL] [Abstract][Full Text] [Related]
3. [Angiotensin II receptor blockers: current status and future prospects].
Corvol P; Plouin PF
Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
[TBL] [Abstract][Full Text] [Related]
4. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis.
Moreira FRC; de Oliveira TA; Ramos NE; Abreu MAD; Simões E Silva AC
Mol Biol Rep; 2021 Sep; 48(9):6619-6629. PubMed ID: 34417705
[TBL] [Abstract][Full Text] [Related]
5. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II pathway inhibitors on post-surgical adhesion band formation: a potential repurposing of old drugs.
Nazari SE; Naimi H; Sayyed-Hosseinian SH; Vahedi E; Daghiani M; Asgharzadeh F; Askarnia-Faal MM; Avan A; Khazaei M; Hassanian SM
Injury; 2022 Nov; 53(11):3642-3649. PubMed ID: 36045032
[TBL] [Abstract][Full Text] [Related]
7. The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury.
Villapol S; Janatpour ZC; Affram KO; Symes AJ
Neurotherapeutics; 2023 Oct; 20(6):1565-1591. PubMed ID: 37759139
[TBL] [Abstract][Full Text] [Related]
8. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
St Peter WL; Odum LE; Whaley-Connell AT
Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
[TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
Ribeiro VT; de Souza LC; Simões E Silva AC
Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
[TBL] [Abstract][Full Text] [Related]
10. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
[TBL] [Abstract][Full Text] [Related]
11. Natural products against renin-angiotensin system for antifibrosis therapy.
Yang T; Chen YY; Liu JR; Zhao H; Vaziri ND; Guo Y; Zhao YY
Eur J Med Chem; 2019 Oct; 179():623-633. PubMed ID: 31279295
[TBL] [Abstract][Full Text] [Related]
12. Role of brain renin-angiotensin system in depression: A new perspective.
Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Albuhadily AK; Hamad RS; Alexiou A; Papadakis M; Saad HM; Batiha GE
CNS Neurosci Ther; 2024 Apr; 30(4):e14525. PubMed ID: 37953501
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer.
Asgharzadeh F; Geraylow KR; Khazaei M; Nassiri M; Hassanian SM; Ferns GA; Avan A
Curr Cancer Drug Targets; 2022; 22(10):785-795. PubMed ID: 35585824
[TBL] [Abstract][Full Text] [Related]
15. Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions.
Rasha F; Ramalingam L; Menikdiwela K; Hernandez A; Moussa H; Gollahon L; Layeequr Rahman R; Moustaid-Moussa N
Exp Cell Res; 2020 Sep; 394(1):112114. PubMed ID: 32504676
[TBL] [Abstract][Full Text] [Related]
16. Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
Bavishi C; Bangalore S; Messerli FH
Prog Cardiovasc Dis; 2016; 59(3):253-261. PubMed ID: 27777044
[TBL] [Abstract][Full Text] [Related]
17. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
Garg M; Royce SG; Tikellis C; Shallue C; Batu D; Velkoska E; Burrell LM; Patel SK; Beswick L; Jackson A; Britto K; Lukies M; Sluka P; Wardan H; Hirokawa Y; Tan CW; Faux M; Burgess AW; Hosking P; Monagle S; Thomas M; Gibson PR; Lubel J
Gut; 2020 May; 69(5):841-851. PubMed ID: 31409604
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer.
Khoshghamat N; Jafari N; Toloue-Pouya V; Azami S; Mirnourbakhsh SH; Khazaei M; Ferns GA; Rajabian M; Avan A
Life Sci; 2021 Apr; 270():119118. PubMed ID: 33548284
[TBL] [Abstract][Full Text] [Related]
19. The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Al-Qahtani Z; Al-Kuraishy HM; Al-Gareeb AI; Albuhadily AK; Ali NH; Alexiou A; Papadakis M; Saad HM; Batiha GE
J Cell Mol Med; 2024 Jun; 28(12):e18495. PubMed ID: 38899551
[TBL] [Abstract][Full Text] [Related]
20. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
